IMP
Process View
regulation of platelet derived growth factor receptor signaling pathway
Any process that modulates the frequency, rate or extent of the platelet-derived growth factor receptor signaling pathway.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of platelet derived growth factor receptor signaling pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FYN | FYN oncogene related to SRC, FGR, YES | 0.996 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.994 | Human | |
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.988 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.986 | ||
| GHR | growth hormone receptor | 0.933 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.684 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.508 | Human | |
| C1QB | complement component 1, q subcomponent, B chain | 0.469 | Human | |
| APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.333 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.291 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.146 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.145 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.142 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.135 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.128 | ||
| EZR | ezrin | 0.088 | ||
| TBXA2R | thromboxane A2 receptor | 0.086 | ||
| SORBS1 | sorbin and SH3 domain containing 1 | 0.086 | ||
| TBC1D10A | TBC1 domain family, member 10A | 0.060 | ||
| DPYSL4 | dihydropyrimidinase-like 4 | 0.060 | ||
| MAPT | microtubule-associated protein tau | 0.059 | ||
| APP | amyloid beta (A4) precursor protein | 0.049 | ||
| SH3GL3 | SH3-domain GRB2-like 3 | 0.045 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.042 | ||
| ADRB2 | adrenergic, beta-2-, receptor, surface | 0.033 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.030 | ||
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.026 | ||
| SPRR2A | small proline-rich protein 2A | 0.026 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.026 | Human | |
| ALB | albumin | 0.024 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.018 | ||
| C17orf28 | chromosome 17 open reading frame 28 | 0.017 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.017 | ||
| FGA | fibrinogen alpha chain | 0.017 | ||
| DPPA4 | developmental pluripotency associated 4 | 0.017 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.017 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.015 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.015 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.014 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.014 | ||
| TNK2 | tyrosine kinase, non-receptor, 2 | 0.014 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.014 | ||
| PTEN | phosphatase and tensin homolog | 0.014 | ||
| EGFR | epidermal growth factor receptor | 0.013 | ||
| MARCO | macrophage receptor with collagenous structure | 0.012 | ||
| SH3GL2 | SH3-domain GRB2-like 2 | 0.011 | ||
| APOE | apolipoprotein E | 0.010 |